Carrico Thomas Joeseph purchased $2K of NRXS
Carrico Thomas Joeseph (CRO, CCO, CPO) purchased 328 shares of Neuraxis, INC (NRXS) at $4.84 on 2026-10-08.
How this was made
The 30-second read
Why it matters
The purchase is too small to move the market but may be noted by algorithmic scans for insider buying.
Market read
Routine insider purchase with limited trading relevance; may be of interest to micro‑cap traders monitoring insider activity.
What to watch
Potential upcoming corporate events not disclosed could make the insider purchase more meaningful.
Background
Form 4 filings disclose insider transactions to the SEC; they are primary sources for insider activity.
Ticker impact
CRO/CCO/Officer Carrico Thomas Joeseph bought 328 shares at $4.84 each, a $1,588 purchase, increasing his holdings to 199,673 shares.
modest upward pressure as market prices in insider buying
The transaction is a routine Form 4 filing with a tiny dollar amount; any impact will be limited.
Market effects
None; the filing does not affect the broader biotech sector.
None; limited to the individual stock.
None
Counterpoint
Given the minuscule size, the purchase may be routine compensation rather than a confidence signal.
Key entities
- CompanyNeuraxis, Inc.
Biotech firm listed on Nasdaq under ticker NRXS.
- PersonCarrico Thomas Joeseph
Chief Revenue Officer, Chief Commercial Officer, and Chief Product Officer at Neuraxis.
